The U.S. Food and Drug Administration (FDA) has approved a label expansion for Nexplanon to allow its manufacturer, Organon (OGN), to market the birth control implant, indicating an efficacy duration ...
The FDA extended the duration of use of Nexplanon for pregnancy prevention in women of reproductive potential for up to 5 years.
A newly published manuscript authored by Dr. Gunda Georg, YourChoice Therapeutics and Columbia University Medical Center ...
When news breaks, you need to understand what actually matters. At Vox, our mission is to help you make sense of the world — and that work has never been more vital. But we can’t do it on our own. We ...
Zacks Investment Research on MSN
Organon secures FDA approval extending NEXPLANON use to five years
Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of ...
China will begin charging a 13% value-added tax on contraceptives starting Jan. 1 while exempting childcare services from the same tax, a move authorities say is part of a broader effort to boost ...
MLK Jr. Day events planned across the Gulf Coast to honor his life and legacy Martin Luther King Jr. Day is Monday, January 19th, and there are several events planned across the Gulf Coast to honor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results